Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPAP; Heliox Effects on Stability and Therapeutics
2005-002585-11Phase 4Terminated
- Sponsor
- Imperial College London
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of heliox21 in respiratory distress syndrome (RDS), sponsored by Imperial College London. Primary endpoint: Work of breathing. Started Aug 2005; status: terminated.
02
Drugs
heliox21
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on 2005-002585-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002585-11.